Edelweiss Us Technology Fund Of Fund Datagrid
Category FoF Overseas
BMSMONEY Rank N/A
Rating N/A
Growth Option
NAV (R) % (D) %
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular
Direct
Nifty 500 TRI 3.82% 15.22% 17.88% 15.87% 14.96%
SIP (XIRR) Regular
Direct
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.25 0.67 1.21 29.08% 0.56
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
24.83% -24.87% -21.84% 0.55 17.59%
Fund AUM As on: 30/06/2025 2635 Cr

No data available

NAV Date:

no data

Review Date:


Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty 500 TRI Cat. Avg Min | Max Rank (In Cat.) Performance
Standard Deviation 24.83
16.27
7.23 | 30.30 43 | 44 Poor
Semi Deviation 17.59
11.40
4.83 | 19.92 43 | 44 Poor
Max Drawdown % -21.84
-14.12
-29.09 | -6.54 40 | 44 Poor
VaR 1 Y % -24.87
-18.37
-32.97 | -7.50 38 | 44 Poor
Average Drawdown % -7.11
-6.86
-21.69 | -1.95 34 | 44 Poor
Sharpe Ratio 1.25
0.97
-0.06 | 1.76 17 | 44 Good
Sterling Ratio 1.21
0.96
0.11 | 1.99 14 | 44 Good
Sortino Ratio 0.67
0.53
0.02 | 1.01 15 | 44 Good
Jensen Alpha % 29.08
16.62
-2.98 | 48.45 3 | 44 Very Good
Treynor Ratio 0.56
1.20
-2.72 | 28.48 14 | 44 Good
Modigliani Square Measure % 20.58
18.56
2.63 | 28.58 18 | 44 Good
Alpha % 34.40
9.94
-10.20 | 41.30 2 | 44 Very Good
Return data last Updated On :
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2025
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty 500 TRI Cat. Avg Min | Max Rank (In Cat.) Performance
Standard Deviation 24.83 16.27 7.23 | 30.30 43 | 44 Poor
Semi Deviation 17.59 11.40 4.83 | 19.92 43 | 44 Poor
Max Drawdown % -21.84 -14.12 -29.09 | -6.54 40 | 44 Poor
VaR 1 Y % -24.87 -18.37 -32.97 | -7.50 38 | 44 Poor
Average Drawdown % -7.11 -6.86 -21.69 | -1.95 34 | 44 Poor
Sharpe Ratio 1.25 0.97 -0.06 | 1.76 17 | 44 Good
Sterling Ratio 1.21 0.96 0.11 | 1.99 14 | 44 Good
Sortino Ratio 0.67 0.53 0.02 | 1.01 15 | 44 Good
Jensen Alpha % 29.08 16.62 -2.98 | 48.45 3 | 44 Very Good
Treynor Ratio 0.56 1.20 -2.72 | 28.48 14 | 44 Good
Modigliani Square Measure % 20.58 18.56 2.63 | 28.58 18 | 44 Good
Alpha % 34.40 9.94 -10.20 | 41.30 2 | 44 Very Good
Return data last Updated On :
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2025
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Edelweiss Us Technology Fund Of Fund NAV Regular Growth Edelweiss Us Technology Fund Of Fund NAV Direct Growth
03-12-2025 32.6519 34.5024
02-12-2025 33.1652 35.044
01-12-2025 32.4158 34.2512
28-11-2025 32.3795 34.2105
26-11-2025 31.911 33.7139
25-11-2025 31.1063 32.8629
24-11-2025 30.9271 32.6728
21-11-2025 29.8297 31.5112
20-11-2025 31.8792 33.6754
19-11-2025 31.3037 33.0667
18-11-2025 30.7684 32.5004
17-11-2025 31.7693 33.5568
14-11-2025 31.629 33.4062
13-11-2025 32.2802 34.0932
12-11-2025 32.9582 34.8085
11-11-2025 33.1393 34.9989
10-11-2025 33.2738 35.1401
07-11-2025 32.1694 33.9713
06-11-2025 33.1508 35.0068

Fund Launch Date: 05/Mar/2020
Fund Category: FoF Overseas
Investment Objective: The primary investment objective of the scheme is to seek to provide long term capital growth by investing predominantly in JPMorgan Funds – US Technology Fund, an equity fund which invests primarily in US technology companies with strong fundamentals. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.
Fund Description: An open ended fund of fund scheme investing in JPMorgan Funds - US Technology Fund
Fund Benchmark: Russel 1000 Equal Weighted Technology Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.